Over recent years, virology, once medicine‘s step-child, moved into the limelight, pushed by impressive progress and pulled by globalisation-induced need for expertise in virus diagnostics and viral epidemics.
Antimicrobial resistance mortality is set to surpass cancer and traffic-related deaths by 2050, according to the UK National Health Service (NHS).
Chronic lung infections caused by the bacterium Pseudomonas aeruginosa require complex and, in most cases, long-term treatment with antibiotics—new medication is badly needed.
Researchers at the Swedish Medical Nanoscience Center at Karolinska Institutet have developed an innovative way of hacking conducting plastics so as to prevent bacterial growth.
The Society for Virology (GfV) which promotes virology through the increase and exchange of research within German speaking countries, as well as via cooperation with other scientific societies, announced this year that a new test can unambiguously confirm the diagnosis of a Zika virus infection – leading to fast diagnosis and identification of an infection.
Saliva is no way to pass a Zika virus infection. According to researchers at the University of Wisconsin–Madison who conducted studies with monkeys, casual contact like kissing or sharing a fork or spoon is not enough for the virus to move between hosts.
A promising Zika vaccine is on its way. Themis Bioscience GmbH (Vienna, Austria), a company specialised in vaccine development, has announced that the firm will receive One milion pounds sterling in funding by the innovation agency of the United Kingdom, Innovate UK, for the further development of this prophylactic vaccine and the conducting of a Phase 1 clinical trial.
A saliva test developed by researchers at the Johns Hopkins Bloomberg School of Public Health nearly matches the performance of a blood test widely used to assess recent or past hepatitis E virus infections, a new study reports. The findings could offer an easier, less expensive alternative to gathering data for studying and eventually treating the disease, which infects an estimated 20 million…
Resident microbes living on the eye are essential for immune responses that protect the eye from infection, new research shows. The study demonstrates the existence of a resident ocular microbiome that trains the developing immune system to fend off pathogens. The research was conducted at the National Eye Institute (NEI), part of the National Institutes of Health. "This is the first…
Summer colds might seem rare, but people are actually just as likely to catch one in the summer as in the winter.
Hospital-acquired infections are both a cause of and contribute to resistance, but a new technology can help.
Beckman Coulter Diagnostics along with partner Diazyme Laboratories announces FDA clearance of a new procalcitonin (PCT) assay, an important tool for the management of bacterial infections and sepsis.
A team of researchers from the University of Würzburg has discovered an interesting enzyme in the pathogens responsible for African sleeping sickness: It could be a promising target for drugs.
Scientists in the UK have developed a new model that will help to advance the study of resistance to antibiotics.
In our interview with the physician Dr. Fabian Berger, we want to know about the advantages of molecular biological procedures compared to conventional C. difficile diagnostics.
An experimental treatment in mice allows the reprogramming of blood cells in order to promote the healing process of cutaneous wounds. This approach could prove to be beneficial in healing challenging wounds in diabetics and major-burn victims.
Research at the University of Konstanz has identified a molecule that allows the bacterium Pseudomonas aeruginosa to inhibit its rival, Staphylococcus aureus. This might build the basis for the development of new antibiotics.
Ebola outbreaks are set to be managed quickly and efficiently – saving lives – with a new approach developed by an international team of researchers, including the University of Warwick, which helps to streamline outbreak decision-making.
Survival of mass extinctions helps to explain near indestructible properties of hospital superbugs.
For almost three quarters of hepatocellular carcinoma (HCC) patients in Europe it is too late for curative treatment because the disease is often only diagnosed at a very advanced stage. Interviewed Professor Guido Gerken MD, Director of the Department for Gastroenterology and Hepatology at University Hospital Essen, about improved and timelier diagnostic capabilities that have already been…
The majority of women suffering with pain when urinating, or needing to urinate often or urgently probably do have a bacterial infection, even when nothing is detected by standard urine testing.
In some cases, the Lassa virus starts with a fever and general weakness, moving toward headache, muscle pain, possible facial swelling, deafness, and worse. About 15 percent of patients hospitalized with severe cases die. Lassa fever is contagious, endemic in West Africa, and Dr. Anthony van den Pol thinks he can use it to cure ovarian cancer.
The ‘Transmission, Prevention, and Reporting of Emerging Infectious Diseases’ program for the International Conference IMED 2016 in Vienna, this November, reflected events in the field of emerging diseases that have occurred over the last two years. Therefore, key congress topics included the Zika virus, the effects of global warming and the unusually high number of hospital-acquired…
SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, has signed an agreement with Thermo Fisher Scientific, the world leader in serving science. The announcement was made at the 27th European Congress of Clinical Microbiology and Infectious Disease (ECCMID) in Vienna to submit its ResistancePlus MG Test for the detection of Mycoplasma genitalium to the US Food & Drug…
Foods should be investigated as a potential source of spread of Clostridium difficile, according to research presented at the 27th ECCMID [1].